Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
Rawa Kamaran IsmailJesper van BreeschotenSilvia van der FlierCaspar van LoosenAnna Maria Gerdina PasmooijMaaike van DartelAlfons J M van den EertweghAnthonius de BoerMichel W J M WoutersDoranne HilariusPublished in: Journal of medical Internet research (2022)
The DICA Medicines Program shows that it is possible to gather and link RWD about medicines to 4 disease-specific population-based registries. Since these RWD became available with minimal registration burden and effort for hospitals, this method can be explored in other population-based registries to evaluate real-world efficacy.